Chunyou Wang

7.0k total citations
157 papers, 4.9k citations indexed

About

Chunyou Wang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Chunyou Wang has authored 157 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 64 papers in Oncology and 59 papers in Surgery. Recurrent topics in Chunyou Wang's work include Pancreatic and Hepatic Oncology Research (43 papers), Pancreatitis Pathology and Treatment (34 papers) and MicroRNA in disease regulation (19 papers). Chunyou Wang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (43 papers), Pancreatitis Pathology and Treatment (34 papers) and MicroRNA in disease regulation (19 papers). Chunyou Wang collaborates with scholars based in China, United States and Hong Kong. Chunyou Wang's co-authors include Heshui Wu, Shanmiao Gou, Gang Zhao, Tao Yin, Shichang Deng, Jiongxin Xiong, Abdulla K. Salahudeen, Shuai Zhu, Jungang Zhang and Qi Qin and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Chunyou Wang

153 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunyou Wang China 43 2.7k 1.9k 1.7k 893 452 157 4.9k
Heshui Wu China 39 2.2k 0.8× 1.3k 0.7× 1.8k 1.1× 1.0k 1.1× 812 1.8× 162 4.7k
Hushan Yang United States 40 2.8k 1.0× 2.0k 1.1× 1.1k 0.7× 438 0.5× 360 0.8× 124 4.6k
Wen‐Chun Hung Taiwan 45 3.1k 1.1× 1.2k 0.6× 1.5k 0.9× 470 0.5× 487 1.1× 143 5.3k
Weiyi Fang China 37 2.9k 1.0× 1.8k 0.9× 1.0k 0.6× 601 0.7× 319 0.7× 138 4.5k
Ye Xu China 38 2.9k 1.1× 2.2k 1.2× 1.9k 1.2× 768 0.9× 723 1.6× 187 5.7k
Yanqiao Zhang China 31 1.9k 0.7× 963 0.5× 1.8k 1.1× 1.0k 1.2× 423 0.9× 154 4.3k
Liang Liu China 39 2.3k 0.8× 1.7k 0.9× 2.6k 1.6× 686 0.8× 896 2.0× 165 5.3k
David W. Dawson United States 42 3.9k 1.4× 1.5k 0.8× 2.3k 1.4× 1.5k 1.6× 774 1.7× 106 7.2k
Xishan Hao China 40 2.6k 0.9× 1.6k 0.8× 1.6k 1.0× 593 0.7× 755 1.7× 150 5.1k

Countries citing papers authored by Chunyou Wang

Since Specialization
Citations

This map shows the geographic impact of Chunyou Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunyou Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunyou Wang more than expected).

Fields of papers citing papers by Chunyou Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunyou Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunyou Wang. The network helps show where Chunyou Wang may publish in the future.

Co-authorship network of co-authors of Chunyou Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chunyou Wang. A scholar is included among the top collaborators of Chunyou Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunyou Wang. Chunyou Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Huifen, et al.. (2023). A New Assessment Method of Vitiligo by Combination of Dermoscopy and Reflectance Confocal Microscopy. Clinical Cosmetic and Investigational Dermatology. Volume 16. 3615–3623. 3 indexed citations
2.
Wang, Chunyou, et al.. (2023). Mapping the evolution of inhaled drug delivery research: Trends, collaborations, and emerging frontiers. Drug Discovery Today. 29(2). 103864–103864. 3 indexed citations
3.
Wang, Chunyou, Liying Liu, Xin Li, et al.. (2023). Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma. Frontiers in Oncology. 13. 1218128–1218128. 6 indexed citations
4.
Zeng, Zhu, Yong Zhao, Shuai Zhu, et al.. (2021). Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Oncogene. 40(36). 5505–5517. 118 indexed citations
5.
Deng, Shi-Jiang, Hengyu Chen, Zhu Zeng, et al.. (2018). Nutrient Stress–Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression. Cancer Research. 79(7). 1398–1412. 103 indexed citations
6.
Niu, Yi, Yan Jin, Shichang Deng, et al.. (2018). MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. Oncogene. 37(13). 1743–1758. 46 indexed citations
7.
Peng, Tao, et al.. (2017). Assessment of Red Blood Cell Distribution Width as an Early Predictor of Persistent Organ Failure in Patients with Acute Pancreatitis. JOP, journal of the pancreas. 18(5). 4 indexed citations
8.
Zhang, Yushun, Feng Guo, Zibo Meng, et al.. (2017). Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure, pancreatic necrosis and mortality in acute pancreatitis. Scientific Reports. 7(1). 8064–8064. 20 indexed citations
9.
Zhao, Gang, Shanmiao Gou, Jiongxin Xiong, et al.. (2015). Etiology, pathology, management and prognosis of chronic pancreatitis in Chinese population: A retrospective study. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(3). 384–389. 3 indexed citations
10.
Gou, Shanmiao, Zhiyong Yang, Tao Liu, Heshui Wu, & Chunyou Wang. (2014). Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials. Critical Care. 18(2). R57–R57. 60 indexed citations
11.
Zhou, Feng, Shanmiao Gou, Jiongxin Xiong, et al.. (2014). Surgical treatment of chronic pancreatitis in young patients. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(5). 701–705. 1 indexed citations
12.
Zhao, Gang, Bo Wang, Yang Liu, et al.. (2013). miRNA-141, Downregulated in Pancreatic Cancer, Inhibits Cell Proliferation and Invasion by Directly Targeting MAP4K4. Molecular Cancer Therapeutics. 12(11). 2569–2580. 128 indexed citations
13.
Zhao, Gang, Jungang Zhang, Yang Liu, et al.. (2012). miR-148b Functions as a Tumor Suppressor in Pancreatic Cancer by Targeting AMPKα1. Molecular Cancer Therapeutics. 12(1). 83–93. 98 indexed citations
14.
15.
Zhou, Wei, Li Wang, Shanmiao Gou, et al.. (2011). ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer. Cancer Letters. 316(2). 178–186. 52 indexed citations
16.
Yan, Ling, Zhiyong Yang, Tao Yin, et al.. (2010). Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro. International Immunopharmacology. 11(2). 187–193. 50 indexed citations
17.
Wang, Chunyou. (2009). Changes of plasma endotoxin and D-lactate during intestinal mucosal barrier injury of acute pancreatitis. Zhonghua putong waike zazhi. 1 indexed citations
18.
Huang, Peng, et al.. (2008). Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma. World Journal of Gastroenterology. 14(24). 3903–3903. 46 indexed citations
19.
Hu, Weiguo, Tao Liu, Jiongxin Xiong, & Chunyou Wang. (2007). Blockade of sonic hedgehog signal pathway enhances antiproliferative effect of EGFR inhibitor in pancreatic cancer cells. Acta Pharmacologica Sinica. 28(8). 1224–1230. 35 indexed citations
20.
Wang, Wei, et al.. (2006). Detection of K-ras Gene Point Mutation's Style in Human Pancreatic Cancer Cell Line PANC-1 by PCR-SSP. The Chinese-German Journal of Clinical Oncology. 5(1). 46–48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heshui Wu Breakdown of academic impact, for papers by Hushan Yang Breakdown of academic impact, for papers by Wen‐Chun Hung Breakdown of academic impact, for papers by Weiyi Fang Breakdown of academic impact, for papers by Ye Xu Breakdown of academic impact, for papers by Yanqiao Zhang Breakdown of academic impact, for papers by Liang Liu Breakdown of academic impact, for papers by David W. Dawson Breakdown of academic impact, for papers by Xishan Hao
Rankless by CCL
2026